1887
Volume 2024, Issue 2
  • EISSN: 2220-2749

Abstract

The procurement of medicines places a heavy burden on the healthcare budget. The emergence of generic medicines as a low-cost alternative to the more expensive branded drugs has been of considerable help to developing countries such as Mauritius. However, the negative perception of the quality and efficacy of generic medicines has always been a controversial topic.

This study focused on understanding patients’ perceptions towards the generic drugs available in the public healthcare sector.

A questionnaire assessing various aspects such as knowledge about generics, beliefs about safety and efficacy of generic drugs, and lack of communication and education about generic medicines was administered to 395 respondents.

A vast majority of the participants (74%) were unaware that the drugs available in public hospitals are generics. Although the respondents believed (76%) that generics were cheaper than branded drugs, they were unaware of the similarity in the composition of generics and branded drugs (55%). Statistically significant relationships were found between demographic factors such as gender, education, and knowledge of generic drugs. Respondents also noted a difference between medicines purchased from private pharmacies and those purchased from public pharmacies. The need to sensitize patient awareness of generic drugs was also identified.

This study was successful in analyzing the factors influencing the knowledge about generic drugs, analyzing the beliefs about safety and efficacy, the perception towards generic medicines in the public and private sectors. Strategies need to be developed to inform healthcare professionals and patients about generic drugs and their potential benefits. However, strict guidelines should be introduced to control the quality, efficacy, and safety of generic drugs before use to increase patient confidence.

© 2024 Author(s), licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/avi.2024.10
2024-12-30
2025-12-14

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/avi/2024/2/avi.2024.10.html?itemId=/content/journals/10.5339/avi.2024.10&mimeType=html&fmt=ahah

References

  1. Bindman AB. Rising Prices and Health Care ‘Empires’. JAMA 2020 Mar 3; 323:(9):815–816. doi: 10.1001/jama.2020.1370.
     [Google Scholar]
  2. Graves JA, Baig K, Buntin M. The financial effects and consequences of COVID-19: A gathering storm. JAMA 2021 Nov 16; 326:(19):1909–1910. doi: 10.1001/jama.2021.18863.
     [Google Scholar]
  3. Charan J, Saxena D, Chaudhari M, Dutta S, Kaur RJ, Bhardwaj P. Opinion of patients seeking primary care regarding prescription of generic drugs: A cross-sectional study. J Family Med Prim Care 2020 Nov 30; 9:(11):5725–5730. doi: 10.4103/jfmpc.jfmpc_1694_20. Dutta et al. (2020).
     [Google Scholar]
  4. Alfonso-Cristancho R, Andia T, Barbosa T, Watanabe JH. Definition and classification of generic drugs across the world. Appl Health Econ Health Policy 2015 Jun 20; 13:(Suppl 1):5–11. doi: 10.1007/s40258-014-0146-1.
     [Google Scholar]
  5. Monteiro WM, Melo GC, Massunari GK, Hübner DV, Tasca RS. Avaliação da disponibilidade de medicamentos genéricos em farmácias e drogarias de Maringá(PR) e comparação de seus preços com os de referência e similares. Rev Bras Cienc Farm. 2005 Sep; 41:(3):333–343. doi: 10.1590/S1516-93322005000300006.
     [Google Scholar]
  6. García AJ, Martos F, Leiva F, Sánchez D. La Cuesta F. (2003) Generic drugs: Good or bad? Physician's knowledge of generic drugs and prescribing habits. Gac Sanit. 2003 Mar–Apr;17(2):144–149. doi: 10.1016/s0213-9111(03)71712-9.
     [Google Scholar]
  7. Vallès JA, Barreiro M, Cereza G, Ferro JJ, Martinez MJ, Cucurrull E, et al. Acceptance of generic prescribing in general practice: Effect of patient education and reference prices. Gac Sanit. 2002 Nov–Dec;(6):505–510. doi: 10.1016/s0213-9111(02)71972-9.
     [Google Scholar]
  8. Arcaro R, da Veig CRP, da Silva WV, Pereira da Veiga C. Attitude and purchase intention to generic drugs. Int J Environ Res Public Health 2021 Apr 26; 18:(9):4579. doi: 10.3390/ijerph18094579.
     [Google Scholar]
  9. Dunne SS, Dunne CP. What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Med 2015 Jul 29;13:173. doi: 10.1186/s12916-015-0415-3.
     [Google Scholar]
  10. Iosifescu A, Halm EA, McGinn T, Siu AL, Federman AD. Beliefs about generic drugs among elderly adults in hospital-based primary care practices. Patient Educ Couns 2008 Nov;73(2):377–383. doi: 10.1016/j.pec.2008.07.012.
     [Google Scholar]
  11. Shrank WH, Cox ER, Fischer MA, Mehta J, Choudhry NK. Patients’ perceptions of generic medications. Health Aff (Millwood). 2009 Mar-Apr;28(2):546–556. doi: 10.1377/hlthaff.28.2.546.
     [Google Scholar]
  12. Alam MM, Sikdar P, Kumar A, Mittal A. Assessing adherence and patient satisfaction with medication: Validation of TSQM in emerging markets. Int J Pharm Healthc Mark. 2018;12(4):409–432. doi: 10.1108/IJPHM-10-2016-0053.
     [Google Scholar]
  13. Joshi SS, Shetty YC, Karande S. Generic drugs - The Indian scenario. J Postgrad Med 2019 Apr–Jun; 65:(2):67–69. doi: 10.4103/jpgm.JPGM_420_18.
     [Google Scholar]
  14. Shikiar R, Rentz AM. Satisfaction with medication: An overview of conceptual, methodologic, and regulatory issues. Value Health 2004 Mar-Apr; 7:(2):204–215. doi: 10.1111/j.1524-4733.2004.72252.x.
     [Google Scholar]
  15. WHO Mauritius, Country Cooperation Strategy at a Glance; 2017. Available from: https://www.who.int/publications/i/item/WHO-CCU-18.02-Mauritius [Accessed on 11 November 2023].
  16. Jeetoo J, Vishal Chand J. An empirical analysis of income elasticity of out-of-pocket healthcare expenditure in Mauritius. Healthcare (Basel). 2022 Jan 5; 10:(1):101. doi: 10.3390/healthcare10010101.
     [Google Scholar]
  17. Health Statistic Report 2021. Available from: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/ https://health.govmu.org/health/wp-content/uploads/2023/03/Health-Statistics-Report-2021.pdf. [Accessed on 11 November 2023].
  18. Guttier MC, Silveira MPT, Luiza VL, Bertoldi AD. Factors influencing the preference for purchasing generic drugs in a Southern Brazilian city. Rev Saude Publica. 2017 Jun 26;51:59. doi: 10.1590/S1518-8787.2017051006786.
     [Google Scholar]
  19. Lleras-Muney A, lichtenberg FR. Are the more educated more likely to use new drugs? Annales d'Économie et de Statistique. 2005; 79/80::671–696. doi: 10.2307/20777592.
     [Google Scholar]
  20. Ito Y, Hara K, Yoo B-K, Tomio J, Kobayashi Y. Can income-based co-payment rates improve disparity? The case of the choice between brand-name and generic drugs. BMC Health Serv Res. 2019 Nov 1; 19:(1):780. doi: 10.1186/s12913-019-4598-8.
     [Google Scholar]
  21. Liang BA, Mackey TK. Prevalence and global health implications of social media in direct-to-consumer drug advertising. J Med Internet Res 2011 Aug 31; 13:(3):e64. doi: 10.2196/jmir.1775.
     [Google Scholar]
  22. Tyrawski J, DeAndrea DC. Pharmaceutical companies and their drugs on social media: A content analysis of drug information on popular social media sites. J Med Internet Res 2015 Jun 1; 17:(6):e130. doi: 10.2196/jmir.4357.
     [Google Scholar]
  23. Toklu HZ, Dülger GA, Hıdıroğlu S, Akici A, Yetim A, Gannemoğlu HM, et al. Knowledge and attitudes of the pharmacists, prescribers and patients towards generic drug use in Istanbul – Turkey. Pharm Pract (Granada). 2012 Dec 31; 10:(4):199–206. Available from: https://www.pharmacypractice.org/index.php/pp/article/view/4.
     [Google Scholar]
  24. Jangra S, Bhyan B, Nair A. Perception on generic drugs among general populace visiting a community pharmacy Jaipur, Rajasthan. J Drug Deliv Ther 2018 Nov–Dec; 8:(6):192–194. doi: 10.22270/jddt.v8i6.2040.
     [Google Scholar]
  25. Tripathi S, Bhattacharya S. Patient perception about generic vs. branded medicines prescribed in a Tertiary Care Hospital in Northern India – a descriptive study. Ind J Pharm Pract. 2018 Apr–Jun; 11:(2):91–95. doi: 10.5530/ijopp.11.2.19.
     [Google Scholar]
  26. Kobayashi E, Karigome H, Sakurada T, Satoh N, Ueda S. Patients’ attitudes towards generic drug substitution in Japan. Health Policy 2011 Jan; 99:(1):60–65. doi: 10.1016/j.healthpol.2010.07.006.
     [Google Scholar]
  27. Sharif SI, Aldayeh S, Alsomali H, Hayat F. Assessment of the knowledge and perception of generic medications among pharmacy and medical students in the University of Sharjah, United Arab Emirates. J Gen Med. Business J Gen Med Sector. 2020 May 28; 16:(3):174113432092664. doi: 10.1177/1741134320926642.
     [Google Scholar]
  28. Regitz-Zagrosek V, Kararigas G. Mechanistic pathways of sex differences in cardiovascular disease. Physiol Rev. 2017 Jan; 97:(1):1–37. doi: 10.1152/physrev.00021.2015.
     [Google Scholar]
  29. Kjoenniksen I, Lindbaek M. Granas AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci 2006 Oct; 28:(5):284–289. doi: 10.1007/s11096-006-9043-5.
     [Google Scholar]
  30. Aivalli PK, Elias MA, Pati MK, Bhanuprakash S, Munegowda C, Shroff ZC, et al. Perceptions of the quality of generic medicines: Implications for trust in public services within the local health system in Tumkur, India. BMJ Glob Health 2018 Jan 13; 2:(Suppl 3):e000644. doi: 10.1136/bmjgh-2017-000644.
     [Google Scholar]
  31. Basu S, Andrews J, Kishore S, Panjabi R, Stuckler D. (2012). Comparative performance of private and public healthcare systems in low- and middle-income countries: A systematic review. PLoS Med. 2012 Jun 19; 9:(6):e1001244. doi: 10.1371/journal.pmed.1001244.
     [Google Scholar]
  32. Al Amer MN, Nayuni N, Anil Kumar KG, Perrett D, Tucker A, Johnston A. The differences between the branded and generic medicines using solid dosage forms: In-vitro dissolution testing. Results Pharma Sci. 2011 Dec 7;2:1–8. doi: 10.1016/j.rinphs.2011.12.001.
     [Google Scholar]
  33. Hohmann NS, Garza KB, Surry D, Hansen RA, Harris I, Kiptanui Z, et al. Communicating benefits and risks of generic drugs to consumers: Patient and caregiver opinions of two FDA-developed educational materials. Res Social Adm Pharm. 2019 Dec; 15:(12):1489–1493. doi: 10.1016/j.sapharm.2019.01.013.
     [Google Scholar]
  34. Hassali MA, Shafie AA, Saleem F, Atif M, Chua GN, Masood I, et al. PHP83 community pharmacist's perceptions towards the quality of locally manufactured generic medicines: A descriptive study from Malaysia. Value Health. 2012 Nov; 15:(7):A623. doi: 10.1016/j.jval.2012.08.127.
     [Google Scholar]
  35. Drozdowska A, Hermanowski T. Exploring factors underlying the attitude of community pharmacists to generic substitution: A nationwide study from Poland. Int J Clin Pharm 2016 Feb; 38:(1):162–170. doi: 10.1007/s11096-015-0227-8.
     [Google Scholar]
  36. Hassali MA, Alrasheedy AA, McLachlan A, Nguyen TA, Al-Tamimi SK, Ibrahim MIM. The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use. Saudi Pharm J 2014 Dec; 22:(6):491–503. doi: 10.1016/j.jsps.2013.12.017.
     [Google Scholar]
/content/journals/10.5339/avi.2024.10
Loading
The generic drug quandary in the Mauritian context: To use or not to use?
Avicenna 2024, 10 (2024); https://doi.org/10.5339/avi.2024.10
/content/journals/10.5339/avi.2024.10
/content/journals/10.5339/avi.2024.10
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): Generic drugs, perception about generic drugs and safety and efficacy of medicines

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error